Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease

Robert Paul; John A. Joska; Carol M. Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi M. Heaps; Victor Valcour; Beau M. Ances; Laurie M. Baker; Lauren E. Salminen; Dan Joseph Stein

doi:10.1007/s13365-014-0293-z

Related publications

Article2016

Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity

Robert Paul, S. K. Phillips, Jacqueline Hoare, David H. Laidlaw, Ryan P. Cabeen, Gayla R. Olbricht, Yuqing Su, Dan Joseph Stein, Susan Engelbrecht, Soraya Seedat, Lauren E. Salminen, Laurie M. Baker, Jodi M. Heaps, John A. Joska

Article2017

Resting-state functional magnetic resonance imaging in clade C HIV: within-group association with neurocognitive function

Lindie Du Plessis, Robert Paul, Jacqueline Hoare, Dan Joseph Stein, Paul A. Taylor, Ernesta M. Meintjes, John A. Joska

Article2019

Impact of left ventricular function on clinical outcomes among patients with coronary artery disease

George C.M. Siontis, Mattia Branca, Patrick W. Serruys, Sigmund Silber, Lorenz Räber, Thomas Pilgrim, Marco Valgimigli, Dik Heg, Stephan Windecker, Lukas Hunziker

European Journal of Preventive Cardiology

Article2019

Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments

Monray Edward Williams, Simo S. Zulu, Dan Joseph Stein, John A. Joska, Petrus J.W. Naudé

Article2023

THE IMPACT OF THE COVID19 PANDEMIC ON PATIENTS WITH PERIPHERAL ARTERY DISEASE

John Tanaka, Dennis I. Narcisse, Lin Gu, Antonio Gutiérrez, Ryan D. Schulteis, Rajesh V. Swaminathan, Jennifer A. Rymer, Simon Jones, Sunil V. Rao